Sales and Marketing

Lonza Group AG and Moderna Inc have entered a deal to develop 1 billion doses of coronavirus vaccines a year. …

Gilead’s antiviral therapy remdesivir has shown tentatively promising efficacy in the race to find an effective treatment for COVID-19, one …

President Donald Trump has vowed to cut the US’s reliance on foreign drugs, singling out China and Ireland as countries …

British scientists are testing an experimental drug to help some of society’s most vulnerable fight off the COVID-19 coronavirus.

US Secretary of State Mike Pompeo claimed that there is evidence the COVID-19 coronavirus was created in a lab, despite …

Bristol Myers Squibb and Acceleron Pharma’s Reblozyl (luspatercept) has secured a positivr opinion from the European Medicines Agency’s Committee for Medicinal …

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given its recommendation for the approval …

The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …

Novartis has revealed that the European Commission has moved to approve Cosentyx (secukinumab) for the treatment of active non-radiographic axial …

The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …

Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …

Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …

Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …

English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …